The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...
Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers of progressive heart failure (HF) such as findings from echocardiogram ...
To wrap up this year's author podcast series, The American Journal of Managed Care® speaks with Angela Liu, PhD, MPH, ...
Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...
CKD complicates cancer treatment, reducing adjuvant chemotherapy use and increasing mortality risk, necessitating ...
Soefje also discusses the growing role of pharmacists, technology, and comparative efficacy data in improving adherence, ...
Heart failure-related deaths in homes or hospices increased from 17.33% in 1999 to 41.15% in 2022, while those in medical facilities and nursing homes decreased. Racial disparities persist, with ...
ACO maturity correlates with improved patient safety, suggesting experience and risk-bearing contracts enhance hospital quality and safety outcomes. Food-as-medicine programs improve nutrition-related ...
Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...
Highlights of the conference coverage from the 2025 European Society of Medical Oncology (ESMO) Congress included content on ...
Experts discuss the unmet needs in desmoid tumor management, emphasizing personalized treatment, quality of life, and the ...
Experts discuss the challenges of diagnosing rare diseases and the potential role of AI in improving patient management and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback